6565 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1978)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary CNS lymphomas prognosis - In reply
    Journal Article

    Abrey, L. E.; Ben-Porat, L.; Panageas, K. S.; Yahalom, J.; Curran, W.; Schultz, C.; Leibel, S.; Nelson, D.; Mehta, M.; De Angelis, L. M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Adoptive transfer of in vitro generated T cell precursors improves T cell reconstitution and mediates graft-versus-tumor activity without graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients
    Meeting Abstract

    Zakrzewski, J. L.; Kochman, A. A.; Lu, S. X.; Terwey, T.; Kim, T. D.; Hubbard, V. M.; Muriglan, S. J.; Suh, D.; Cabrera-Perez, J.; Heller, G.; more...
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Correlation of planning scan anatomy and PSA relapse in prone prostate cancer patients
    Meeting Abstract

    Yorke, E. D.; Jackson, A.; Venkatraman, E. S.; Skwarchuk, M. W.; Bauer, J.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save
  • Single fraction image guided intensity modulated radiotherapy for paraspinal metastases
    Meeting Abstract

    Yamada, Y.; Lovelock, M.; Bilsky, M.; Venkatraman, E.; Toner, S.; Johnson, J.; Zatcky, J.; Fuks, Z.
    Radiotherapy and Oncology (2006)

    Fulltext@MSK | Save
  • Majority of transformed lymphomas have high SUVs on PET scanning similar to diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Weissler, M.; Noy, A.; Schoder, H.; Gonen, M.; Yeung, H.
    Blood (2006)

    Fulltext@MSK | Save
  • Optimizing chemotherapy administration: A phase I study of biweekly capecitabine dose and schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Panageas, K.; Hodgman, E.; Norton, L.; Hudis, C. A.
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Letrozole (L) with bevacizumab (B) is feasible in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Rugo, H.; Caravelli, J.; Yeh, B.; Panageas, K.; Bruckner, J.; Norton, L.; Park, J.; Hudis, C.; Dickler, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Melanomas arising in nevus-prone individuals are more likely to harbor a BRAF/NRAS mutation
    Meeting Abstract

    Thomas, N. E.; Alexander, A.; Edmiston, S. N.; Millikan, R. C.; Groben, P.; Hao, H.; Tolbert, D.; Berwick, M.; Busam, K.; Begg, C.; more...
    Journal of Investigative Dermatology (2006)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A phase II study of single agent depsipeptide (DEP) in patients (pts) with radio-active iodine (RAI)-refractory, metastatic, thyroid carcinoma: Preliminary toxicity and efficacy experience
    Meeting Abstract

    Su, Y. B.; Tuttle, R. M.; Fury, M.; Ghossein, R.; Singh, B.; Herman, K.; Venkatraman, E. S.; Stambuk, H.; Robbins, R.; Pfister, D. G.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save